Zheng Gen Jin

2.0k total citations
39 papers, 1.4k citations indexed

About

Zheng Gen Jin is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Zheng Gen Jin has authored 39 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 10 papers in Cancer Research and 7 papers in Immunology. Recurrent topics in Zheng Gen Jin's work include Cancer-related molecular mechanisms research (6 papers), Angiogenesis and VEGF in Cancer (5 papers) and Hippo pathway signaling and YAP/TAZ (5 papers). Zheng Gen Jin is often cited by papers focused on Cancer-related molecular mechanisms research (6 papers), Angiogenesis and VEGF in Cancer (5 papers) and Hippo pathway signaling and YAP/TAZ (5 papers). Zheng Gen Jin collaborates with scholars based in United States, China and Germany. Zheng Gen Jin's co-authors include Suowen Xu, Jaroslav Pelisek, Meimei Yin, Marina Koroleva, Peter J. Little, Chang Hoon Ha, Shuya Zhang, Weiye Wang, Yanni Xu and Shuyi Si and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Circulation Research.

In The Last Decade

Zheng Gen Jin

39 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zheng Gen Jin United States 24 825 252 226 177 173 39 1.4k
Jiang‐Yun Luo China 19 648 0.8× 189 0.8× 200 0.9× 199 1.1× 361 2.1× 29 1.3k
Panjamaporn Sangwung United States 18 750 0.9× 164 0.7× 138 0.6× 124 0.7× 99 0.6× 23 1.3k
Huaiping Zhu United States 21 674 0.8× 135 0.5× 246 1.1× 154 0.9× 194 1.1× 27 1.4k
Yue Han China 22 843 1.0× 308 1.2× 190 0.8× 128 0.7× 167 1.0× 52 1.4k
Rui Cheng United States 28 974 1.2× 184 0.7× 156 0.7× 118 0.7× 116 0.7× 52 1.8k
Yuyu Yang China 25 888 1.1× 235 0.9× 210 0.9× 107 0.6× 48 0.3× 45 1.3k
Junlian Gu China 26 1.2k 1.4× 265 1.1× 120 0.5× 427 2.4× 101 0.6× 57 1.9k
Yaguang Bi China 18 725 0.9× 172 0.7× 160 0.7× 202 1.1× 289 1.7× 23 1.4k
Nikolay Patrushev United States 14 1.0k 1.2× 201 0.8× 369 1.6× 107 0.6× 219 1.3× 15 1.7k
Yunbiao Lu United States 14 660 0.8× 172 0.7× 220 1.0× 118 0.7× 58 0.3× 17 1.3k

Countries citing papers authored by Zheng Gen Jin

Since Specialization
Citations

This map shows the geographic impact of Zheng Gen Jin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zheng Gen Jin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zheng Gen Jin more than expected).

Fields of papers citing papers by Zheng Gen Jin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zheng Gen Jin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zheng Gen Jin. The network helps show where Zheng Gen Jin may publish in the future.

Co-authorship network of co-authors of Zheng Gen Jin

This figure shows the co-authorship network connecting the top 25 collaborators of Zheng Gen Jin. A scholar is included among the top collaborators of Zheng Gen Jin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zheng Gen Jin. Zheng Gen Jin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Shunwang, Jinque Luo, Huan Liu, et al.. (2024). ASGR1 Deficiency Inhibits Atherosclerosis in Western Diet–Fed ApoE −/− Mice by Regulating Lipoprotein Metabolism and Promoting Cholesterol Efflux. Arteriosclerosis Thrombosis and Vascular Biology. 44(12). 2428–2449. 9 indexed citations
2.
Luo, Jinque, Huan Liu, Yanni Xu, et al.. (2024). Hepatic Sirt6 activation abrogates acute liver failure. Cell Death and Disease. 15(4). 283–283. 7 indexed citations
3.
Li, Feng, et al.. (2024). Network pharmacology and in vivo evidence of the pharmacological mechanism of geniposide in the treatment of atherosclerosis. BMC Complementary Medicine and Therapies. 24(1). 53–53. 4 indexed citations
4.
Xu, Haiyang, et al.. (2023). Epidemiology and survival of patients with central nervous system solitary fibrous tumors: A population-based analysis. Frontiers in Oncology. 12. 977629–977629. 4 indexed citations
5.
Wang, Jinping, Jinque Luo, Dante Rotili, et al.. (2023). SIRT6 Protects Against Lipopolysaccharide-Induced Inflammation in Human Pulmonary Lung Microvascular Endothelial Cells. Inflammation. 47(1). 323–332. 16 indexed citations
6.
Wu, Xiaoqian, Huan Liu, Suowen Xu, et al.. (2022). SIRT6 Mitigates Heart Failure With Preserved Ejection Fraction in Diabetes. Circulation Research. 131(11). 926–943. 56 indexed citations
8.
Jiang, Shanshan, Hui Li, Lianhua Piao, et al.. (2020). Computational study on new natural compound inhibitors of indoleamine 2,3-dioxygenase 1. Aging. 12(12). 11349–11363. 9 indexed citations
10.
Zhang, Shuya, JY Kim, Suowen Xu, et al.. (2020). Endothelial-specific YY1 governs sprouting angiogenesis through directly interacting with RBPJ. Proceedings of the National Academy of Sciences. 117(9). 4792–4801. 17 indexed citations
11.
Jin, Zheng Gen, et al.. (2020). <p>Long Non-Coding RNA PART1 Exerts Tumor Suppressive Functions in Glioma via Sponging miR-190a-3p and Inactivation of PTEN/AKT Pathway</p>. OncoTargets and Therapy. Volume 13. 1073–1086. 33 indexed citations
12.
Zhuang, Yan, et al.. (2018). MicroRNA-337-5p participates in the development and progression of osteosarcoma via ERBB, MAPK and VEGF pathways.. PubMed. 22(17). 5460–5470. 5 indexed citations
13.
Xu, Suowen, Danielle Kamato, Peter J. Little, et al.. (2018). Targeting epigenetics and non-coding RNAs in atherosclerosis: from mechanisms to therapeutics. Pharmacology & Therapeutics. 196. 15–43. 125 indexed citations
14.
Xu, Suowen, Yanni Xu, Meimei Yin, et al.. (2018). Flow-dependent epigenetic regulation of IGFBP5 expression by H3K27me3 contributes to endothelial anti-inflammatory effects. Theranostics. 8(11). 3007–3021. 60 indexed citations
15.
Xu, Suowen, Jaroslav Pelisek, & Zheng Gen Jin. (2018). Atherosclerosis Is an Epigenetic Disease. Trends in Endocrinology and Metabolism. 29(11). 739–742. 130 indexed citations
16.
Xu, Yanni, Peng Liu, Suowen Xu, et al.. (2017). Tannic acid as a plant-derived polyphenol exerts vasoprotection via enhancing KLF2 expression in endothelial cells. Scientific Reports. 7(1). 6686–6686. 52 indexed citations
17.
Xu, Suowen, Marina Koroleva, Meimei Yin, & Zheng Gen Jin. (2016). Atheroprotective laminar flow inhibits Hippo pathway effector YAP in endothelial cells. Translational research. 176. 18–28.e2. 73 indexed citations
18.
Xu, Suowen, Chang Hoon Ha, Weiye Wang, et al.. (2015). PECAM1 regulates flow-mediated Gab1 tyrosine phosphorylation and signaling. Cellular Signalling. 28(3). 117–124. 24 indexed citations
19.
Wang, Weiye, Suowen Xu, Meimei Yin, & Zheng Gen Jin. (2014). Essential roles of Gab1 tyrosine phosphorylation in growth factor-mediated signaling and angiogenesis. International Journal of Cardiology. 181. 180–184. 36 indexed citations
20.
Jin, Zheng Gen, et al.. (2013). miR-125b Inhibits Connexin43 and Promotes Glioma Growth. Cellular and Molecular Neurobiology. 33(8). 1143–1148. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026